Literature DB >> 33564616

Non-invasive multimodal imaging of Diabetic Retinopathy: A survey on treatment methods and Nanotheranostics.

Rajkumar Sadasivam1, Gopinath Packirisamy2, Snehlata Shakya3, Mayank Goswami1.   

Abstract

Diabetes Retinopathy (DR) is one of the most prominent microvascular complications of diabetes. It is one of the pre-eminent causes for vision impairment followed by blindness among the working-age population worldwide. The de facto cause for DR remains challenging, despite several efforts made to unveil the mechanism underlying the pathology of DR. There is quite less availability of the low cost pre-emptive theranostic imaging tools in terms of in-depth resolution, due to the multiple factors involved in the etiology of DR. This review work comprehensively explores the various reports and research works on all perspectives of diabetic retinopathy (DR), and its mechanism. It also discusses various advanced non-destructive imaging modalities, current, and future treatment approaches. Further, the application of various nanoparticle-based drug delivery strategies used for the treatment of DR are also discussed. In a nutshell, the present review work bolsters the pursuit of the development of an advanced non-invasive optical imaging modal with a nano-theranostic approach for the future diagnosis and treatment of DR and its associated ocular complications. © The author(s).

Entities:  

Keywords:  diabetic retinopathy; drugs and nano-theranostics; imaging biomarkers; treatment

Mesh:

Substances:

Year:  2021        PMID: 33564616      PMCID: PMC7868006          DOI: 10.7150/ntno.56015

Source DB:  PubMed          Journal:  Nanotheranostics        ISSN: 2206-7418


  178 in total

Review 1.  The impact of nanobiotechnology on the development of new drug delivery systems.

Authors:  O Kayser; A Lemke; N Hernández-Trejo
Journal:  Curr Pharm Biotechnol       Date:  2005-02       Impact factor: 2.837

Review 2.  The blood-brain barrier/neurovascular unit in health and disease.

Authors:  Brian T Hawkins; Thomas P Davis
Journal:  Pharmacol Rev       Date:  2005-06       Impact factor: 25.468

Review 3.  Engineered nanoparticles as precise drug delivery systems.

Authors:  T C Yih; M Al-Fandi
Journal:  J Cell Biochem       Date:  2006-04-15       Impact factor: 4.429

Review 4.  Pharmacokinetic aspects of retinal drug delivery.

Authors:  Eva M Del Amo; Anna-Kaisa Rimpelä; Emma Heikkinen; Otto K Kari; Eva Ramsay; Tatu Lajunen; Mechthild Schmitt; Laura Pelkonen; Madhushree Bhattacharya; Dominique Richardson; Astrid Subrizi; Tiina Turunen; Mika Reinisalo; Jaakko Itkonen; Elisa Toropainen; Marco Casteleijn; Heidi Kidron; Maxim Antopolsky; Kati-Sisko Vellonen; Marika Ruponen; Arto Urtti
Journal:  Prog Retin Eye Res       Date:  2016-12-24       Impact factor: 21.198

Review 5.  Unique optical coherence tomographic features in age-related macular degeneration.

Authors:  Sumit Randhir Singh; Marco Lupidi; Sai Bhakti Mishra; Manuel Paez-Escamilla; Giuseppe Querques; Jay Chhablani
Journal:  Surv Ophthalmol       Date:  2020-01-22       Impact factor: 6.048

Review 6.  Roles of the conjunctiva in ocular drug delivery: a review of conjunctival transport mechanisms and their regulation.

Authors:  Ken-ichi Hosoya; Vincent H L Lee; Kwang-Jin Kim
Journal:  Eur J Pharm Biopharm       Date:  2005-07       Impact factor: 5.571

7.  Anti-angiogenic effect of bare titanium dioxide nanoparticles on pathologic neovascularization without unbearable toxicity.

Authors:  Dong Hyun Jo; Jin Hyoung Kim; Jin Gyeong Son; Nam Woong Song; Yong-Il Kim; Young Suk Yu; Tae Geol Lee; Jeong Hun Kim
Journal:  Nanomedicine       Date:  2014-02-22       Impact factor: 5.307

8.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Authors:  D M Nathan; S Genuth; J Lachin; P Cleary; O Crofford; M Davis; L Rand; C Siebert
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

9.  Therapeutic regulation of VE-cadherin with a novel oligonucleotide drug for diabetic eye complications using retinopathy mouse models.

Authors:  Ka Ka Ting; Yang Zhao; Weiyong Shen; Paul Coleman; Michelle Yam; Tailoi Chan-Ling; Jia Li; Thorleif Moller; Mark Gillies; Mathew A Vadas; Jennifer R Gamble
Journal:  Diabetologia       Date:  2018-11-15       Impact factor: 10.122

10.  In vivo wide-field multispectral scanning laser ophthalmoscopy-optical coherence tomography mouse retinal imager: longitudinal imaging of ganglion cells, microglia, and Müller glia, and mapping of the mouse retinal and choroidal vasculature.

Authors:  Pengfei Zhang; Azhar Zam; Yifan Jian; Xinlei Wang; Yuanpei Li; Kit S Lam; Marie E Burns; Marinko V Sarunic; Edward N Pugh; Robert J Zawadzki
Journal:  J Biomed Opt       Date:  2015       Impact factor: 3.170

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.